[Hormone therapy and risk of venous thromboembolism: new insights from the ESTHER study]

MeSH terms

• Activated Protein C Resistance / chemically induced
• Administration, Cutaneous
• Administration, Oral
• Aged
• Estrogen Replacement Therapy / adverse effects
• Estrogen Replacement Therapy / methods
• Estrogens / administration & dosage
• Estrogens / adverse effects
• Estrogens / therapeutic use
• Female
• Hemostasis / physiology
• Hormone Replacement Therapy / adverse effects*
• Hormone Replacement Therapy / methods
• Humans
• Liver / metabolism
• Menopause*
• Middle Aged
• Norpregnanes / administration & dosage
• Norpregnanes / adverse effects
• Norpregnanes / therapeutic use
• Pregnanes / administration & dosage
• Pregnanes / adverse effects
• Pregnanes / therapeutic use
• Progesterone / administration & dosage
• Progesterone / adverse effects
• Progesterone / therapeutic use
• Risk
• Venous Thrombosis / chemically induced*
• Venous Thrombosis / epidemiology